Aug. 8, 2025—Evident announced a definitive agreement to acquire Pramana. Evident’s CEO Wes Pringle said in a news release that Evident’s acquisition of Pramana represents a collaborative opportunity to expand its growing digital pathology product offering. “Pramana’s innovation and capabilities complement and expand the technologies Evident can provide to keep pace with daily caseloads, automate quality control, seamlessly integrate data and communication systems, and take advantage of the industry’s newest advances in AI-driven imaging and analysis,” according to the press release.
Pramana, based in Cambridge, Mass., was established in 2021 as a spin-off of Nference. Evident was acquired by private equity firm Bain Capital in 2023, a year after it was established as a wholly owned subsidiary of Olympus. Evident is headquartered in Tokyo and supported by R&D and manufacturing centers in Japan, the United States, Germany, and China.